AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed Eduardo Uribe to senior director of quality services at the company’s Charleston, SC parenteral manufacturing facility. Uribe will oversee the facility’s quality control organization as the company expands its manufacturing facility footprint.

“We’re excited to bring a talented director such as Eduardo to the team,” said Brian Dillion, senior director of quality at AAIPharma. “Eduardo’s experience with developing, implementing and managing quality systems for biotechnology and pharmaceutical companies and his comprehensive understanding of GMP compliance make him a great asset for AAIPharma.”

With more than 20 years of experience in the biotech and pharmaceutical industry, Uribe brings a wealth of global knowledge and understanding of GMP, ISO and EU guidelines. His experience base includes virology, forensic toxicology, bacterial, viral and recombinant vaccines manufacturing and expertise in a variety of fill/finish operations.

Uribe has served in a variety of executive roles at SmithKline Beecham, Merck & Co., and SkyePharma. Most recently, he was a quality systems manager at EMD Millipore, in San Diego and Temecula, California. Prior to that, he was a senior director of quality operations for Irvine Pharmaceutical Services.

Uribe is a graduate of Kutztown University where he earned a Bachelor of Science degree.

About AAIPharma Services Corporation

AAIPharma Services Corp. is a leading provider of contract services that encompass the entire process of pharmaceutical drug development from discovery through commercialization. The company’s wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, and clinical and commercial contract manufacturing and packaging. AAIPharma Services serves more than 500 clients around the globe. It is headquartered in Wilmington, North Carolina. For more information on the company, visit .